arcadia

SUVEN LIFE SCIENCES LTD.

NSE : SUVENBSE : 530239ISIN CODE : INE495B01038Industry : Pharmaceuticals & DrugsHouse : Private
BSE221.55-2.55 (-1.14 %)
PREV CLOSE ( ) 224.10
OPEN PRICE ( ) 223.20
BID PRICE (QTY) 221.55 (84)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22540
TODAY'S LOW / HIGH ( )220.10 227.45
52 WK LOW / HIGH ( )163.3 337.7
NSE221.45-3.5 (-1.56 %)
PREV CLOSE( ) 224.95
OPEN PRICE ( ) 224.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 131160
TODAY'S LOW / HIGH( ) 220.55 227.70
52 WK LOW / HIGH ( )161 337.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 09-03 1989
Management Info
Venkateswarlu Jasti - Chairman - Managing Director
Registered Office

Address 8-2-334, S D E Serene Chambers,6th Floor, Road No 5, Avenue 7,Banjara Hills,
Hyderabad,
Telangana-500034

Phone +91-40- 23541142 23543311 32921695 32921696

Email info@suven.com

Website www.suven.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
06Feb Suven Life Science acquires Suven Phar
Suven Life Science has acquired all the shares of Suven Pharmaceuticals..
06Feb Suven Life Science gains on acquiring
Suven Life Sciences is currently trading at Rs. 206.10, up by 0.55 point..
06Feb Suven Life Sciences’ net profit in Q3
Suven Life Sciences has reported results for third quarter ended Decembe..
30Jan Suven Life Sciences informs about reco
Suven Life Sciences has informed that the Company has fixed February 15,..
16Jan Suven Life Sciences secures Product Pa
Suven Life Sciences (Suven) has secured one product patent from Australi..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit252.331584.27
Gross Profit 352.2 2302.66
Operating Profit 413.582561.87
Net Sales 1290.216252.57
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 361.90 (9.70%)
M.Cap ( in Cr)144.38
Themis Medicare (BSE)
 305.00 (8.73%)
M.Cap ( in Cr)280.02
Everest Organics (BSE)
 157.65 (16.86%)
M.Cap ( in Cr)126.12
Pfizer (BSE)
 2907.45 (0.58%)
M.Cap ( in Cr)13300.92
Jenburkt Pharma (BSE)
 474.90 (3.28%)
M.Cap ( in Cr)217.95
Shareholding Pattern
PROMOTERS 60%
NON-INSTITUTION 31.52%
MUTUAL FUNDS/UTI 1.73%
FI/BANKS/INSURANCE 0.29%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM